Taysha Gene Therapies, Inc.(TSHA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TSHA Taysha Gene Therapies, Inc.

Trading 04-01 14:53:54 EDT

1.26

-0.13

-9.71%

High1.40	Low1.21	Vol4.04M
Open1.38	D1 Closing1.39	Amplitude13.68%
Mkt Cap257.28M	Tradable Cap161.34M	Total Shares205.00M
T/O5.09M	T/O Rate3.14%	Tradable Shares128.55M
P/B3.60	ROE-121.94%	EPS-0.36
52wk High4.32	52wk Low1.17	P/E-3.52
Dividend0.00	Div.Yield0.00	ROA-32.51%

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"TSHA","market":"US","secType":"STK","nameCN":"Taysha Gene Therapies, Inc.","latestPrice":1.255,"timestamp":1743533619346,"preClose":1.39,"halted":0,"volume":4040242,"delay":0,"floatShares":128554637,"shares":205001632,"eps":-0.357,"marketStatus":"Trading","change":-0.135,"latestTime":"04-01 14:53:50 EDT","open":1.38,"high":1.4001,"low":1.21,"amount":5090024.139223,"amplitude":0.136763,"askPrice":1.26,"askSize":5057,"bidPrice":1.25,"bidSize":10820,"shortable":0,"etf":0,"ttmEps":-0.357,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Market Trading","tradingStatus":3,"beginTime":1743537600000},"marketStatusCode":2,"adr":0,"listingDate":1600920000000,"exchange":"NASDAQ","adjPreClose":1.39,"preHourTrading":{"tag":"盘前","latestPrice":1.4,"preClose":1.39,"latestTime":"09:11 EDT","volume":18439,"amount":26214.003491199997,"timestamp":1743513091926},"postHourTrading":{"tag":"盘后","latestPrice":1.42,"preClose":1.39,"latestTime":"19:57 EDT","volume":38176,"amount":53583.4077,"timestamp":1743465476321},"volumeRatio":1.254495,"impliedVol":2.3713,"impliedVolPercentile":0.9283},"requestUrl":"/m/hq/s/TSHA/wiki","defaultTab":"wiki","newsList":[{"id":"2524491531","title":"Biotech stocks slide as Marks resignation seen being negative for sector","url":"https://stock-news.laohu8.com/highlight/detail?id=2524491531","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524491531?lang=en_us&edition=full_marsco","pubTime":"2025-04-01 23:50","pubTimestamp":1743522637,"startTime":"0","endTime":"0","summary":"Shares of several biotech and biopharma names are under pressure on Monday following the resignation of the head of the Food and Drug Administration’s Center for Biologics Evaluation and Research, Peter Marks. RBC Capital says the development is “not good for the biotech industry even beyond vaccines.” Voicing a similar opinion, BMO Capital told investors this morning that it sees the news as a “significant negative” for the biopharma and biotech sectors.Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks.“NOT GOOD” FOR BIOTECH SECTOR: RBC Capital believes the resignation of the head of the FDA’s Center for Biologics Evaluation and Research, Peter Marks, is “not good for the biotech industry even beyond vaccines.” Marks had been a key advocate for more flexible, efficient approval processes for drugs, particularly those for orphan diseases such as gene therapies, the firm tells investors in a research note.PRICE ACTION: In mornin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/biotech-stocks-slide-marks-resignation-155037694.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biotech-stocks-slide-marks-resignation-155037694.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["DTIL","BK4007","BK4551","LEGN","TSHA","LU1069344957.HKD","LU2023250504.SGD","FDMT","BK4139","RCKTW","MGTX","LU0058720904.USD","DYN","LU2462157665.USD","KPTI","NGNE","LU1571399168.USD","PCRX","PRME","LU1035775433.USD","VRTX","IE0009355771.USD","IE00BFTCPJ56.SGD","GILD","RGNX","LU1430594728.SGD","RCKT","SRPT","REGN","LU1066053197.SGD","LU2362540622.SGD","RNA","BK4532","NTLA","BK4568","GLPG","IE0002141913.USD","CRSP","VERV","BEAM","LU0320765992.SGD","MGX","LU0417517546.SGD","LU0823416689.USD","LU2468319806.SGD","BK4578","MRNA","IE00BZ9MQY76.HKD","IE00B4R5TH58.HKD","IE00B3T34201.USD","PTCT","LU1066051498.USD"],"gpt_icon":1},{"id":"2524047975","title":"BUZZ-U.S. STOCKS ON THE MOVE-Veritex, Gaming and Leisure Properties, Apple","url":"https://stock-news.laohu8.com/highlight/detail?id=2524047975","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524047975?lang=en_us&edition=full_marsco","pubTime":"2025-04-01 02:29","pubTimestamp":1743445744,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Veritex, Gaming and Leisure Properties, AppleMarch 31 (Reuters) - The S&P 500 and the Nasdaq declined on Monday, with technology stocks among the largest fallers, as inves","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nL3N3QE16T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLPI","TSYW.SI","PL","LYV","LU0316494557.USD","RKT","ALSN","PG","TSHA","LU1674673428.USD","PINS","BK4017","SG9999015358.SGD","LU0820561818.USD","LITB","HMST","NOVA","SLDB","NEM","GSK.UK","BK4539","FLG","GT","IDYA","LPLA","SRPT","ENZ","LU1674673691.USD","BK4532","NVAX","FBK","LU1145028129.USD","LU2552382215.SGD","GATE","EBS","COOP","ELTX","IIPR","SSBK","ALNY","LU0061475181.USD","VBTX","BLUE","SG9999014567.USD","AIG"],"gpt_icon":1},{"id":"2524975989","title":"US STOCKS-S&P 500, Nasdaq slip as investors await major tariff news","url":"https://stock-news.laohu8.com/highlight/detail?id=2524975989","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524975989?lang=en_us&edition=full_marsco","pubTime":"2025-04-01 02:17","pubTimestamp":1743445063,"startTime":"0","endTime":"0","summary":"US STOCKS-S&P 500, Nasdaq slip as investors await major tariff newsFocus on tariffs, data and FedTrump to announce extensive tariffs on WednesdayS&P, Nasdaq eye worst quarter since 2022Indexes: Dow up 0.23%, S&P 500 down 0.38%, Nasdaq down 1.18%Updates to mid-afternoon pricingBy David French","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nL3N3QE14Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HD","NVIW.SI","LU2506951958.HKD","RKT","LU1804176565.USD","LU0345774631.USD","LU1551013425.SGD","NVDU","LU2236285917.USD","LU0823414551.USD","NVDA","NVDS.UK","IE00BQXX3C00.GBP","LU0985481810.HKD","LU0795875086.SGD","NVDD","LU0106261372.USD","LU2361044865.SGD","NVD3.UK","NVDY","LU2458330169.SGD","LU0476273544.USD","LU0048573561.USD","SLDB","LU1244550494.USD","SG9999015986.USD","IE0034235295.USD","NVDS","SG9999014559.SGD","SG9999013999.USD","TSYW.SI","TSHA","SF","2NVD.UK","COOP","LU0979878070.USD","SNVD.UK","BK4083","3NVD.UK","NVDX","LU2242650005.HKD","LU2041044095.USD","NVD2.UK"],"gpt_icon":1},{"id":"2523245499","title":"Dow Gains Over 100 Points; NewGenIvf Group Shares Plummet","url":"https://stock-news.laohu8.com/highlight/detail?id=2523245499","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523245499?lang=en_us&edition=full_marsco","pubTime":"2025-03-31 23:51","pubTimestamp":1743436301,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/25/03/44565615/dow-gains-over-100-points-newgenivf-group-shares-plummet","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TQQQ","SQQQ","NVIW.SI","QLD","PCVX","SSBK","LU1559883803.SGD","TSYW.SI","BK4195","BK4211","PSQ","LU0053671581.USD","USAW.SI","USJW.SI","BK4007","BK4229","BK4532","BK4196","IE0009354923.USD","PCOM","MNQmain","TSHA","COOP","BK4139","NIVF","LU0566484027.USD",".IXIC","NQmain","QID","BK4122","BK4539","CORT"],"gpt_icon":1},{"id":"2523942739","title":"Shares of Gene Therapy Makers and Developers Fall After Report That FDA Official Peter Marks Has Resigned","url":"https://stock-news.laohu8.com/highlight/detail?id=2523942739","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523942739?lang=en_us&edition=full_marsco","pubTime":"2025-03-31 21:34","pubTimestamp":1743428086,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QE0YC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4535","BK4556","BEAM","IE00BJJMRZ35.SGD","BK4611","IE00BJT1NW94.SGD","SLDB","BK4505","IE00BFTCPJ56.SGD","BK4139","IE0002141913.USD","IE0009355771.USD","BK4585","IE00B2B36J28.USD","TSHA","BK4588","SRPT"],"gpt_icon":0},{"id":"2523420539","title":"Solid Biosciences Down 10.5%, Taysha Gene Therapies Down 14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2523420539","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523420539?lang=en_us&edition=full_marsco","pubTime":"2025-03-31 21:34","pubTimestamp":1743428086,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QE0YC:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SRPT","IE0002141913.USD","BK4535","BK4505","IE00B2B36J28.USD","BK4611","BK4588","BK4139","IE0009355771.USD","SLDB","TSHA","BEAM","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","BK4585","BK4556"],"gpt_icon":0},{"id":"2523439339","title":"BUZZ-U.S. STOCKS ON THE MOVE-Gene therapy cos, gold miners, chipmakers","url":"https://stock-news.laohu8.com/highlight/detail?id=2523439339","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523439339?lang=en_us&edition=full_marsco","pubTime":"2025-03-31 19:48","pubTimestamp":1743421708,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Gene therapy cos, gold miners, chipmakersEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call news","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nL6N3QE0ED:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SRPT","IIPR","LU2756315664.SGD","CRSP","LU2054465674.USD","NVDS.UK","LU2290526834.HKD","NEM","LU0511384066.AUD","LU1066051225.USD","NVDA","LU0203347892.USD","AU","VRAX","3NVD.UK","MRNA","SLDB","NMAX","2NVD.UK","NVIW.SI","LU0320765489.SGD","NVDX","NVDY","X","NVD3.UK","USAW.SI","LU1720051017.SGD","LU1732799900.SGD","NVDU","SG9999014567.USD","SNVD.UK","MACW.SI","NVD2.UK","TSHA","NVD","TSYW.SI","BLUE","NVDS","STLD","LU0788108826.HKD","NVDD"],"gpt_icon":1},{"id":"2523915913","title":"BUZZ-Gene therapy makers slide on reports that FDA official Peter Marks resigns","url":"https://stock-news.laohu8.com/highlight/detail?id=2523915913","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523915913?lang=en_us&edition=full_marsco","pubTime":"2025-03-31 17:55","pubTimestamp":1743414925,"startTime":"0","endTime":"0","summary":"BUZZ-Gene therapy makers slide on reports that FDA official Peter Marks resigns ** Shares of gene therapy makers and developers slide premarket after WSJ and other media outlets report that Peter Mark","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nL3N3QE0HZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BEAM","BK4556","SLDB","TSHA","BK4139","BK4588","BK4535","BK4505","BK4611"],"gpt_icon":0},{"id":"2517480019","title":"Taysha Gene Therapies announces inducement grant under Nasdaq listing rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2517480019","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517480019?lang=en_us&edition=full_marsco","pubTime":"2025-03-07 21:11","pubTimestamp":1741353080,"startTime":"0","endTime":"0","summary":"Taysha Gene Therapies (TSHA) announced that, on March 3, 2025, the Compensation Committee of Taysha’s Board of Directors granted three new employee...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/taysha-gene-therapies-announces-inducement-grant-under-nasdaq-listing-rule-11?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/taysha-gene-therapies-announces-inducement-grant-under-nasdaq-listing-rule-11?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4139","SQQQ","TSYW.SI","BK4112","NQmain","IE00BKPKM429.USD","IE00B3QW5Z07.USD","QID","NVIW.SI","LU2210149790.SGD","QLD","IE00BGHQF748.EUR","BK4588","IE00B64PRP62.GBP","USJW.SI","TSHA","LU2210150020.SGD","TQQQ","NDAQ","LU2095319765.USD","MNQmain","USAW.SI",".IXIC","PSQ"],"gpt_icon":0},{"id":"2517808014","title":"Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517808014","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517808014?lang=en_us&edition=full_marsco","pubTime":"2025-03-07 21:00","pubTimestamp":1741352400,"startTime":"0","endTime":"0","summary":"DALLAS, March 07, 2025  -- Taysha Gene Therapies, Inc.  , a clinical-stage biotechnology company focused on advancing adeno-associated virus -based gene therapies for severe monogenic diseases of the central nervous system , today announced that, on March 3, 2025, the Compensation Committee of Taysha's Board of Directors granted three new employees, in the aggregate, options to purchase 225,000 shares of the Company's common stock in connection with their employment. The stock options were granted under the Taysha Gene Therapies, Inc. 2023 Inducement Plan as an inducement material to the individuals entering employment with Taysha in accordance with Nasdaq Listing Rule 5635.Company Contact:Hayleigh Collins Senior Director, Corporate Communications & Investor RelationsTaysha Gene Therapies, Inc.hcollins@tayshagtx.com","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/taysha-gene-therapies-announces-inducement-130000785.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B3QW5Z07.USD","BK4139","BK4135","BK4588","BK4585","LU2210149790.SGD","BK4112","NDAQ","IE00BGHQF748.EUR","LU2210150020.SGD","CNS","TSHA","IE00B64PRP62.GBP","LU2095319765.USD",".IXIC","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2516689995","title":"Buy Rating Reiterated for Taysha Gene Therapies Amid Positive Clinical Data and Strong Financial Position","url":"https://stock-news.laohu8.com/highlight/detail?id=2516689995","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516689995?lang=en_us&edition=full_marsco","pubTime":"2025-03-02 02:05","pubTimestamp":1740852336,"startTime":"0","endTime":"0","summary":"In a report released on February 27, Whitney Ijem from Canaccord Genuity maintained a Buy rating on Taysha Gene Therapies (TSHA – Research Report),...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-reiterated-for-taysha-gene-therapies-amid-positive-clinical-data-and-strong-financial-position?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-reiterated-for-taysha-gene-therapies-amid-positive-clinical-data-and-strong-financial-position?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TSHA"],"gpt_icon":0},{"id":"2514367175","title":"Taysha Gene Therapies’ Positive Earnings Call Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2514367175","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514367175?lang=en_us&edition=full_marsco","pubTime":"2025-02-28 10:49","pubTimestamp":1740710977,"startTime":"0","endTime":"0","summary":"Taysha Gene Therapies, Inc. (($TSHA)) has held its Q4 earnings call. Read on for the main highlights of the call. Taysha Gene Therapies’ recent ear...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/taysha-gene-therapies-positive-earnings-call-highlights?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/taysha-gene-therapies-positive-earnings-call-highlights?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TSHA"],"gpt_icon":0},{"id":"2514740138","title":"Positive Outlook for Taysha Gene Therapies: Buy Rating Backed by FDA Progress and Strong Financial Position","url":"https://stock-news.laohu8.com/highlight/detail?id=2514740138","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514740138?lang=en_us&edition=full_marsco","pubTime":"2025-02-27 18:37","pubTimestamp":1740652664,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Yanan Zhu from Wells Fargo maintained a Buy rating on Taysha Gene Therapies (TSHA – Research Report), with a price ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/positive-outlook-for-taysha-gene-therapies-buy-rating-backed-by-fda-progress-and-strong-financial-position?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/positive-outlook-for-taysha-gene-therapies-buy-rating-backed-by-fda-progress-and-strong-financial-position?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRGS","TSHA"],"gpt_icon":0},{"id":"2514187767","title":"Taysha Gene Therapies Full Year 2024 Earnings: Beats Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2514187767","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514187767?lang=en_us&edition=full_marsco","pubTime":"2025-02-27 18:17","pubTimestamp":1740651453,"startTime":"0","endTime":"0","summary":"NasdaqGS:TSHA Earnings and Revenue Growth February 27th 2025. All figures shown in the chart above are for the trailing 12 month  period. Revenue exceeded analyst estimates by 1.1%. Earnings per share  also surpassed analyst estimates by 4.6%.Looking ahead, revenue is forecast to grow 58% p.a. on average during the next 3 years, compared to a 20% growth forecast for the Biotechs industry in the US.The company's shares are down 1.2% from a week ago.It is worth noting though that we have found 2 warning signs for Taysha Gene Therapies that you need to take into consideration.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/taysha-gene-therapies-full-2024-101733756.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TSHA"],"gpt_icon":0},{"id":"2514844543","title":"Q4 2024 Taysha Gene Therapies Inc Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2514844543","media":"Thomson Reuters StreetEvents","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514844543?lang=en_us&edition=full_marsco","pubTime":"2025-02-27 14:04","pubTimestamp":1740636255,"startTime":"0","endTime":"0","summary":"Hayleigh Collins; Director, Head of Corporate Communications and Investor Relations; Taysha Gene Therapies Inc. Ladies and gentlemen, good morning and welcome to the Taysha Gene Therapies full year 2024 conference call. . As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Hayleigh Collins, Director, Head of corporate communications and Investor relations. Please go ahead.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/q4-2024-taysha-gene-therapies-060415944.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TSHA"],"gpt_icon":0},{"id":"2514684661","title":"Taysha Gene Therapies Reports 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2514684661","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514684661?lang=en_us&edition=full_marsco","pubTime":"2025-02-27 12:46","pubTimestamp":1740631606,"startTime":"0","endTime":"0","summary":"Taysha Gene Therapies, Inc. ( ($TSHA) ) has released its Q4 earnings. Here is a breakdown of the information Taysha Gene Therapies, Inc. presented ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/taysha-gene-therapies-reports-2024-financial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/taysha-gene-therapies-reports-2024-financial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2514936892","title":"Taysha Gene Therapies Is Maintained at Buy by Chardan Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2514936892","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514936892?lang=en_us&edition=full_marsco","pubTime":"2025-02-27 06:59","pubTimestamp":1740610740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TSHA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 26, 2025 17:59 ET (22:59 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSHA"],"gpt_icon":0},{"id":"2514286489","title":"Positive Outlook on Taysha Gene Therapies: Promising Developments and Financial Stability","url":"https://stock-news.laohu8.com/highlight/detail?id=2514286489","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514286489?lang=en_us&edition=full_marsco","pubTime":"2025-02-27 03:36","pubTimestamp":1740598619,"startTime":"0","endTime":"0","summary":"Analyst Gil Blum of Needham maintained a Buy rating on Taysha Gene Therapies (TSHA – Research Report), retaining the price target of $6.00. Gil Blu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/positive-outlook-on-taysha-gene-therapies-promising-developments-and-financial-stability?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/positive-outlook-on-taysha-gene-therapies-promising-developments-and-financial-stability?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"2514435855","title":"Taysha Gene Therapies Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2514435855","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514435855?lang=en_us&edition=full_marsco","pubTime":"2025-02-26 22:32","pubTimestamp":1740580340,"startTime":"0","endTime":"0","summary":"Taysha Gene Therapies Inc reports results for the quarter ended December 31 - Earnings SummaryTaysha Gene Therapies Inc TSHA.OQ reported a quarterly adjusted loss of 7 cents per share for the quarter ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nL5N3PH1W5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSHA"],"gpt_icon":0},{"id":"2514778852","title":"Taysha Gene Therapies, Inc. (TSHA) Reports Q4 Loss, Tops Revenue Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2514778852","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514778852?lang=en_us&edition=full_marsco","pubTime":"2025-02-26 22:15","pubTimestamp":1740579305,"startTime":"0","endTime":"0","summary":"Taysha Gene Therapies, Inc.  came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to earnings of $0.35 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 12.50%. A quarter ago, it was expected that this company would post a loss of $0.08 per share when it actually produced a loss of $0.09, delivering a surprise of -12.50%.Taysha Gene Therapies , which belongs to the Zacks Medical - Generic Drugs industry, posted revenues of $2.02 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 6.42%. This compares to year-ago revenues of $3.6 million. The company has topped consensus revenue estimates just once over the last four quarters.Taysha Gene Therapies shares have lost about 1.7% since the beginning of the year versus the S&P 500's gain of 1.3%.While Taysha Gene Therapies has underperformed the market so far thi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/taysha-gene-therapies-inc-tsha-141505681.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TSHA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tayshagtx.com","stockEarnings":[{"period":"1week","weight":-0.1627},{"period":"1month","weight":-0.1313},{"period":"3month","weight":-0.1965},{"period":"6month","weight":-0.322},{"period":"1year","weight":-0.5157},{"period":"ytd","weight":-0.1965}],"compareEarnings":[{"period":"1week","weight":-0.0256},{"period":"1month","weight":-0.0586},{"period":"3month","weight":-0.0455},{"period":"6month","weight":-0.0166},{"period":"1year","weight":0.0694},{"period":"ytd","weight":-0.0455}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN7 disease; TSHA-118 for the treatment of CLN1 disease; TSHA-105 for the treatment of for SLC13A5 Deficiency; and TSHA-101 for the treatment of GM2 gangliosidosis. Taysha Gene Therapies, Inc. has a strategic partnership with The University of Texas Southwestern Medical Center to develop and commercialize transformative gene therapy treatments. The company was incorporated in 2019 and is based in Dallas, Texas.","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.177294},{"month":2,"riseRate":0.4,"avgChangeRate":0.109391},{"month":3,"riseRate":0.2,"avgChangeRate":-0.123298},{"month":4,"riseRate":0.25,"avgChangeRate":-0.087217},{"month":5,"riseRate":0.25,"avgChangeRate":-0.029549},{"month":6,"riseRate":0.25,"avgChangeRate":-0.00003},{"month":7,"riseRate":0.5,"avgChangeRate":-0.021321},{"month":8,"riseRate":0.75,"avgChangeRate":0.9233},{"month":9,"riseRate":0,"avgChangeRate":-0.14195},{"month":10,"riseRate":0,"avgChangeRate":-0.151796},{"month":11,"riseRate":0.6,"avgChangeRate":0.174321},{"month":12,"riseRate":0.6,"avgChangeRate":-0.073382}],"exchange":"NASDAQ","name":"Taysha Gene Therapies, Inc.","nameEN":"Taysha Gene Therapies, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Taysha Gene Therapies, Inc.(TSHA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Taysha Gene Therapies, Inc.(TSHA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Taysha Gene Therapies, Inc.,TSHA,Taysha Gene Therapies, Inc.股票,Taysha Gene Therapies, Inc.股票老虎,Taysha Gene Therapies, Inc.股票老虎国际,Taysha Gene Therapies, Inc.行情,Taysha Gene Therapies, Inc.股票行情,Taysha Gene Therapies, Inc.股价,Taysha Gene Therapies, Inc.股市,Taysha Gene Therapies, Inc.股票价格,Taysha Gene Therapies, Inc.股票交易,Taysha Gene Therapies, Inc.股票购买,Taysha Gene Therapies, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Taysha Gene Therapies, Inc.(TSHA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Taysha Gene Therapies, Inc.(TSHA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction